ALEXANDRIA, Va., Dec. 15 -- Arkay Therapeutics, East Windsor Township, New Jersey, has been assigned a patent (9,839,644) developed by Ravi Seshagirirao Kumar, East Windsor Township, New Jersey, for "formulations and methods for treatment of metabolic syndrome." The abstract states: "Formulations and methods of providing an orally-active anti-metabolic disease Fixed Dose Combinations (FDC) for use as personalized medicine to treat different components of the Metabolic Syndrome or Insulin resista . . .